Navigation Links
New England Journal of Medicine Study Highlights Need for Rapid, PCR-based Group B Streptococcus (GBS) Testing at Time of Admission for Labor and Delivery
Date:6/24/2009

d diseases by automating otherwise complex manual laboratory procedures. The company's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges. Through its strong molecular biology capabilities, the company is focusing on those applications where rapid molecular testing is particularly important, such as identifying infectious disease and cancer in the clinical market; food, agricultural, and environmental testing in the industrial market; and identifying bio-terrorism agents in the biothreat market. See http://www.cepheid.com for more information.

This press release contains forward-looking statements that are not purely historical regarding Cepheid's or its management's intentions, beliefs, expectations and strategies for the future, including those relating to product performance and future market opportunities. Because such statements deal with future events, they are subject to various risks and uncertainties, and actual results could differ materially from the company's current expectations. Factors that could cause actual results to differ materially include risks and uncertainties such as those relating to: regulatory developments and changing therapeutic practices regarding testing levels and methods; the failure of products to perform as expected, whether due to manufacturing errors, defects or otherwise; the impact of competitive products and pricing; reimbursement rates for the products; and underlying market conditions worldwide. Readers should also refer to the section entitled "Risk Factors" in Cepheid's Annual Report on Form 10-K for 2008 and in its most recent quarterly report on Form 10-Q, each filed with the Securities and Exchange Commission.

All forward-looking statements and reasons why
'/>"/>

SOURCE Cepheid
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Gene Therapy Field Advances With Important Clinical Findings Reported in the New England Journal of Medicine
2. New England Peptide Forms Scientific Advisory Board
3. NeoStem Secures $250,000 in an Above Market Financing and Expands Its Relationship With New England Cryogenic Center, Inc.
4. New England Peptide Names Director of Chemical Development
5. New England Peptide Implements Quality Management System, Prepares for ISO 9001: 2008 Registration
6. Over and Under(R) Pericardium Covered Stent is now in use in England and Proves Great Deliverability
7. NeoStem Announces Private Placement Financing to Advance Marketing Campaign; Financing Includes Investment from New England Cryogenic Center
8. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
9. Tandem Labs New England Facility Doubles Discovery Support Capacity - Increasing Foothold in New England
10. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
11. Statement From Michael Hansen, CEO of Elseviers Health Sciences Division, Regarding Australia Based Sponsored Journal Practices Between 2000 and 2005
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... 02, 2015 In the five years ... has experienced robust growth. The industry, which consists of ... energy resources and other goods, has grown on account ... As a result, IBISWorld forecasts that industry revenue will ... $946.8 million over the five-year period, including an anticipated ...
(Date:3/2/2015)... British Columbia , March 2, 2015 /PRNewswire/ ... a clinical stage biopharmaceutical company specializing in the ... Craig Schneider , Chief Executive Officer, will ... at VirtualInvestorConferences.com. DATE: Thursday, March 5, ... click the red "register/ watch event now" button ...
(Date:3/2/2015)... Calif. , March 2, 2015  Asterias Biotherapeutics, ... the emerging field of regenerative medicine, today announced that ... financial and operating results on Tuesday, March 10, 2015 ... Company will host a conference call and webcast on ... 1:30 p.m. Pacific to discuss the results and recent ...
(Date:3/2/2015)... Boston, Massachusetts (PRWEB) March 02, 2015 ... legal services, today announced the addition of Debbie Casey ... group’s capabilities in the healthcare space. , ... industry, most of which with Fresenius Medical Care North ... will leverage her extensive experience to work with Outside ...
Breaking Biology Technology:Laboratory Testing Services in Canada Industry Market Research Report Now Available from IBISWorld 2Laboratory Testing Services in Canada Industry Market Research Report Now Available from IBISWorld 3InMed Pharmaceuticals to Present Investor Webcast March 5 2Asterias Biotherapeutics to Report Fourth Quarter and Full Year 2014 Results on March 10, 2015 2Outside GC Expands Healthcare Team 2
... that word? It was as popular in Web circles in the ... long and short of it was that the Web was going ... to consumers, either in business or retail. , ,Everybody still in ... would get better prices, and so would consumers. A real win-win ...
... was going to write todays column about a toilet seat. ... the fact that Iand 99 otherseven had this toilet seat ... to become part of the Silicon Valley 100. This group, ... is a group of 100 individuals who, by virtue of ...
... Inc. , has agreed to acquire California-based AlphaSmart, ... K-12 students, for $57 million. , ,Renaissance, based in ... and operate the company as a wholly owned subsidiary. ... deal, which is expected to be completed by the ...
Cached Biology Technology:A funny thing happened on the way out of the back office 2A funny thing happened on the way out of the back office 3The myth of objectivity 2The myth of objectivity 3
(Date:2/5/2015)... Feb. 5, 2015  Marken is starting its 35 ... has launched a new marketing campaign to solidify its ... The new campaign focuses on First as ... shipments. The first headline in the series, ... priorities with its client,s priorities. Marken recognizes the need ...
(Date:2/5/2015)... IRVINE, Calif. , Jan. 27, 2015 ... trusted provider of globally deployed, innovative test ... today announced the delivery of its ... Martin Space Systems Company (LMSSC). GENASYS is ... the demands of mission-critical applications that require ...
(Date:2/5/2015)... 2015 Research and Markets ( ... "Global Biometrics Market (2014-2020): Market Forecast By ... report to their offering. , ... is anticipated to overtake North ... government spending towards IT security, government biometric based ...
Breaking Biology News(10 mins):Marken Launches New Patient-Centric Campaign 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3
... University of North Carolina at Chapel Hill School of Medicine ... collateral circulation the "back-up" blood vessels that can provide ... attack or stroke. The new knowledge could help inform ... drugs or procedures that can cause new collaterals to form ...
... "The Sign of the Four" Sherlock Holmes tells Watson he ... and pipe-tobacco, "with colored plates illustrating the difference in the ... miscreants who happen to smoke during the commission of a ... pipe dottle don,t have a patch on geologists and the ...
... closer to understanding what triggers muscle damage in one ... facioscapulohumeral muscular dystrophy (FSHD). FSHD affects about 1 ... and wasting of muscles in the face, shoulders and ... disabling. The facial weakness in FSHD, for example, ...
Cached Biology News:Genetics underlie formation of body's back-up bypass vessels 2Geologists revisit the Great Oxygenation Event 2Geologists revisit the Great Oxygenation Event 3Geologists revisit the Great Oxygenation Event 4Geologists revisit the Great Oxygenation Event 5Geologists revisit the Great Oxygenation Event 6Discovery opens door to therapeutic development for FSH muscular dystrophy 2
Nuclear/Cytosol Fractionation Kit Research Focus: other Storage Temperature: 4C Shipping Temperature: 4C...
Peptide-affinity Purified Polyclonal Antibody to MTR...
Polyclonal Antibody to AGAP1 / Centaurin, gamma 2...
Polyclonal Antibody to PRG3...
Biology Products: